Abstract:Summary Objectives The primary objective of this study is to investigate if false vocal folds (FVF) or simultaneous FVF with thyroarytenoid (FVF + TA) Botox® injections achieve comparable treatment effects to standard TA injections. This study also aims to determine how patient-reported outcomes contribute to the transition to, and continuation of, FVF or FVF + TA injections. Methods Retrospective chart review was performed for all patients receiving Botox® for adductor spasmodic dysphonia at a laryngology practice between 2005 and 2018. Twenty out of 103 patients met the study's inclusion criteria. All subjects began standard treatment with TA injections. Based on response to injection, patients either continued to receive TA injections (group TA; n = 7), switched to FVF injections (group FVF; n = 7), or switched to FVF + TA injections (group FVF + TA; n = 6). A comparison of group means before and after initiation of FVF ± TA injections was performed between groups FVF and FVF + TA to group TA for the injection dosage, the duration of injection cycles, the patient-reported duration of best voice, and the presence and duration of breathiness and choking. Within-group observations were also compared before and after FVF ± TA injections. Results There were no significant findings for the variables between group FVF and group TA before FVF injections. The duration of injection cycles was significantly shorter for group FVF than group TA after FVF injections (95% CI: − 66.05, − 0.34; P = 0.05). However, duration of best voice quality, breathiness, and choking were similar ( P > 0.05) for group FVF to group TA after FVF injections. Group FVF + TA had a significantly shorter duration of injection cycles (95% CI: − 66.97, − 3.22; P = 0.03), best voice (95% CI: − 0.76, − 0.03; P = 0.04), and choking (95% CI: − 2.68, 0.02; P = 0.05) than group TA before FVF + TA injections. Group FVF + TA displayed a similar duration ( P > 0.05) of injection cycles, best voice quality, breathiness, and choking to group TA after FVF + TA injections. Within-group, increased duration of injection cycles and best voice were observed after FVF ± TA injections for both group FVF and FVF + TA. Acute adverse events were variable within groups after FVF ± TA injections. Conclusion This study compared outcomes of FVF or FVF + TA injections to successive TA injections among patients. FVF injections displayed similar duration of best voice quality, breathiness, and choking to TA injections. FVF + TA injections achieved similar duration of injection cycles, best voice quality, breathiness, and choking to TA injections. This study demonstrates that patients guided by a reduced duration of adverse events, while tolerating a shorter injection cycle, may benefit from initiation and continuation of FVF injections. Patients guided by increased duration of injection cycle and best voice, while tolerating the duration of adverse events, may benefit from initiation and continuation of FVF + TA injections.

Systemic Effects and Absorption of Subepithelial Dexamethasone Vocal Fold Injections

Factors Associated With Improvement Following In‐office Steroid Injections for Vocal Fold Scar

Acute Effects of Steroids on Vocal Fold Epithelium Post‐injury in a Preclinical Model

Phosphorylation of the glucocorticoid receptor alters SMAD signaling in vocal fold fibroblasts

The impact of intravenous versus submucosal dexamethasone on short‐term patient response: A randomized controlled trial

Effects of intra-space injection of Twin mix versus intraoral-submucosal, intramuscular, intravenous and per-oral administration of dexamethasone on post-operative sequelae after mandibular impacted third molar surgery: a preliminary clinical comparative study

High performance liquid chromatography determination of dexamethasone in plasma to evaluate its systemic absorption following intra-space pterygomandibular injection of twin-mix (mixture of 2 % lignocaine with 1:200,000 epinephrine and 4 mg dexamethasone): randomized control trial

Does Intralesional Steroid Injection Effectively Mitigate Vocal Fold Scarring in A Rabbit Model?

Retroductal dexamethasone administration promotes the recovery from obstructive and inflammatory salivary gland dysfunction

Salivary cortisol concentration changes after epidural steroid injection.

Effects of Low‐dose Dexamethasone on Inflammatory Factors in Drainage Fluid and Wound Healing after Thyroid Surgery During Perioperative Period

Submucosal dexamethasone injection improves quality of life measures after third molar surgery: a comparative study

Corticosteroid Effects on Upper Esophageal Sphincter Function in Anterior Cervical Discectomy and Fusion: A Study Using High-Resolution Impedance Manometry

Determination of the Dexamethasone in the Cochlear Tissue after Postaurical and Intramuscular Injection

[Local combined with systemic glucocorticoid treatment of young and middle-aged patients with severe and profound hearing loss]

[The effect of intratympanic dexamethasone or methylprednisolone on treatment of sudden sensorineural hearing loss].

Patient-Reported Outcomes after False Vocal Folds Injections for Adductor Spasmodic Dysphonia

Intratympanic dexamethasone with hyaluronic acid in the treatment of idiopathic sudden sensorineural hearing loss after failure of intravenous steroid and vasoactive therapy

The Pharmacokinetic Profiles of Dexamethasone and Methylprednisolone Concentration in Perilymph and Plasma Following Systemic and Local Administration

Perioperative dexamethasone reduces post-surgical sequelae of wisdom tooth removal. A split-mouth randomized double-masked clinical trial

Clinical observation of submucosal injection with different doses of dexamethasone to improve postoperative symptoms of mandibular third molar extraction